Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-16-767874
Filing Date
2016-11-14
Accepted
2016-11-14 17:00:12
Documents
73
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A d267451d10qa.htm 10-Q/A 564579
2 EX-31.1 d267451dex311.htm EX-31.1 6320
3 EX-31.2 d267451dex312.htm EX-31.2 6437
4 EX-32.1 d267451dex321.htm EX-32.1 3769
5 EX-32.2 d267451dex322.htm EX-32.2 3901
  Complete submission text file 0001193125-16-767874.txt   3920795

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jnp-20160331.xml EX-101.INS 767903
7 XBRL TAXONOMY EXTENSION SCHEMA jnp-20160331.xsd EX-101.SCH 45550
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jnp-20160331_cal.xml EX-101.CAL 69483
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnp-20160331_def.xml EX-101.DEF 152375
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnp-20160331_lab.xml EX-101.LAB 340656
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnp-20160331_pre.xml EX-101.PRE 267745
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-10352 | Film No.: 161995785
SIC: 2834 Pharmaceutical Preparations